Loading companies…
Loading companies…
China · Biotech · Healthtech
Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-Series B | $17.5M | Changshu Guofa Venture — Role not disclosedFudan Capital — Role not disclosedKunsheng Relay Fund — Role not disclosed |